Financhill
Sell
44

SARTF Quote, Financials, Valuation and Earnings

Last price:
$202.25
Seasonality move :
10.46%
Day range:
$202.25 - $202.25
52-week range:
$175.93 - $313.00
Dividend yield:
0.39%
P/E ratio:
62.80x
P/S ratio:
3.89x
P/B ratio:
4.81x
Volume:
--
Avg. volume:
14
1-year change:
-27.51%
Market cap:
$14B
Revenue:
$3.7B
EPS (TTM):
$3.22

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Sartorius AG has -- downside to fair value with a price target of -- per share.

SARTF vs. S&P 500

  • Over the past 5 trading days, Sartorius AG has underperformed the S&P 500 by -2.83% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Sartorius AG does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Sartorius AG revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Sartorius AG reported revenues of $872.8M.

Earnings Growth

  • Sartorius AG earnings have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter Sartorius AG reported earnings per share of $0.23.
Enterprise value:
19.3B
EV / Invested capital:
--
Price / LTM sales:
3.89x
EV / EBIT:
44.66x
EV / Revenue:
5.35x
PEG ratio (5yr expected):
--
EV / Free cash flow:
51.03x
Price / Operating cash flow:
41.75x
Enterprise value / EBITDA:
22.35x
Gross Profit (TTM):
$1.6B
Return On Assets:
1.98%
Net Income Margin (TTM):
5.96%
Return On Equity:
6.35%
Return On Invested Capital:
2.42%
Operating Margin:
8.59%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $4.4B $3.8B $3.6B $882.7M $872.8M
Gross Profit $2.3B $1.9B $1.6B $385.8M $379.5M
Operating Income $1.2B $747.4M $481.2M $99.8M $75M
EBITDA $1.4B $1.1B $862.9M $197.7M $199.3M
Diluted EPS $8.36 $5.54 $3.22 $0.24 $0.23
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $1.7B $2B $2.2B $2.1B --
Total Assets $4.9B $6.6B $7B $10.5B --
Current Liabilities $816.3M $1.7B $2.3B $1.4B --
Total Liabilities $3.5B $4.6B $4.5B $7.6B --
Total Equity $1.4B $2B $2.5B $2.9B --
Total Debt $2.4B $2.3B $2.4B $5.5B --
Trailing 12 Months Fiscal Quarters
Period Ending 2022-06-30 2023-06-30 2024-06-30 2023-06-30 2024-06-30
Cash Flow Statement
Cash Flow Operations $811.1M $860.6M $902.1M $178M $324.1M
Cash From Investing -$794.9M -$1.2B -$3B -$208.7M -$110.3M
Cash From Financing -$255.5M $292.9M $2.5B $31.5M -$771.2M
Free Cash Flow $272.4M $216.6M $377.9M -$3.5M $218.1M
SARTF
Sector
Market Cap
$14B
$44.7M
Price % of 52-Week High
--
51.72%
Dividend Yield
0.39%
0%
Shareholder Yield
--
-0.75%
1-Year Price Total Return
-27.51%
-33.41%
Beta (5-Year)
1.016
0.746
Dividend yield:
0.39%
Annualized payout:
$1.55
Payout ratio:
25.13%
Growth streak:
2 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $197.68
200-day SMA
Sell
Level $211.17
Bollinger Bands (100)
Buy
Level 190.07 - 209.41
Chaikin Money Flow
Sell
Level -1.8K
20-day SMA
Buy
Level $190.70
Relative Strength Index (RSI14)
Buy
Level 63.73
ADX Line
Buy
Level 30.16
Williams %R
Sell
Level 0
50-day SMA
Buy
Level $192.91
MACD (12, 26)
Buy
Level 2.53
25-day Aroon Oscillator
Buy
Level 20
On Balance Volume
Neutral
Level 10.9K

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
Sell
CA Score (Annual)
Level (-1.2088)
Buy
Beneish M-Score (Annual)
Level (-2.9399)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (1.8873)
Buy
Piotroski F Score (Annual)
Level (5)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.

Stock Forecast FAQ

In the current month, SARTF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SARTF average analyst price target in the past 3 months is --.

  • Where Will Sartorius AG Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Sartorius AG share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Sartorius AG?

    Analysts are divided on their view about Sartorius AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sartorius AG is a Sell and believe this share price will rise from its current level to --.

  • What Is Sartorius AG's Price Target?

    The price target for Sartorius AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is SARTF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Sartorius AG is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of SARTF?

    You can purchase shares of Sartorius AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sartorius AG shares.

  • What Is The Sartorius AG Share Price Today?

    Sartorius AG was last trading at $202.25 per share. This represents the most recent stock quote for Sartorius AG. Yesterday, Sartorius AG closed at $202.25 per share.

  • How To Buy Sartorius AG Stock Online?

    In order to purchase Sartorius AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Sirius XM Be a 10-Bagger Stock?
Will Sirius XM Be a 10-Bagger Stock?

Last year, Warren Buffett surprised practically everyone when he acquired…

Will Quantum Computing Disrupt NVIDIA?
Will Quantum Computing Disrupt NVIDIA?

Earlier this month, NVIDIA CEO Jensen Huang seemingly dashed the…

What Trump Presidency Means For Stock Market
What Trump Presidency Means For Stock Market

Donald Trump was the first president in modern U.S. history…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Buy
59
NUKK alert for Jan 21

Nukkleus [NUKK] is up 7.25% over the past day.

Sell
45
QMCO alert for Jan 21

Quantum [QMCO] is up 14.36% over the past day.

Buy
51
QRVO alert for Jan 21

Qorvo [QRVO] is up 3.99% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock